Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Accu Target Medipharma (Shanghai) Co. Ltd. operates in the Medical Devices & Mechanical Engineering technology area and currently has 1 pending office action. This action indicates a focused and limited engagement with the patent office, likely centered on a specific Medical Devices & Mechanical Engineering innovation. The prosecution is being handled by 1 distinct examiner, HUPCZEY, JR, RONALD JAMES, who is also the busiest examiner for the portfolio. This concentration suggests that the company's current intellectual property efforts are being evaluated by the official, allowing for a very targeted legal strategy that focuses on the specific requirements of the examiner. Practitioners can observe that the prosecution efforts are not currently spread across different concurrent disputes, allowing for a concentrated allocation of legal resources toward this particular matter.
The entire active portfolio is confined to a distinct art unit, reflecting a specialized technological focus. For practitioners, this means that the company's immediate success in securing patent rights depends entirely on the resolution of the pending office action. Since HUPCZEY, JR, RONALD JAMES is the examiner involved, the prosecution strategy can be tailored specifically to the requirements and interpretive style of the individual. The focus within the Medical Devices & Mechanical Engineering field suggests that Accu Target Medipharma (Shanghai) Co. Ltd. is prioritizing a specific set of innovations at this time, and the outcome of the pending action will be a significant determinant of the company's immediate patenting success. Understanding the examiner's previous rulings will be essential to anticipate the trajectory of this portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUPCZEY, JR, RONALD JAMES | 1 | 64.7% | +22.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254813 | MULTICHANNEL CRYOABLATION SYSTEM AND CONTROL METHOD THEREFOR | HUPCZEY, JR, RONALD JAMES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254813 | MULTICHANNEL CRYOABLATION SYSTEM AND CONTROL METHOD THEREFOR | HUPCZEY, JR, RONALD JAMES | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18254813 | MULTICHANNEL CRYOABLATION SYSTEM AND CONTROL METHOD THEREFOR | HUPCZEY, JR, RONALD JAMES | 3794 | §103§112 | Non-Final OA | — | Pending | May 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial